BB Biotech (BION)

Last close As at 29/11/2024

CHF37.35

0.20 (0.54%)

Market capitalisation

CHF2,059m

BB Biotech, a Switzerland-based investment company, targets long-term capital growth from biotechnology companies developing and marketing innovative drugs. At least 90% of the portfolio is held in listed companies, primarily those that already have products on the market or promising drug candidates in advanced stages of development. BION is benchmarked against the Nasdaq Biotech Index (in CHF) but is managed on a bottom-up basis, with a focused c 20–35 stock portfolio.

Latest Insights

View More

Investment Companies | Flash note

BB Biotech — A key milestone with significance for the sector

Investment Companies | edison tv

BB Biotech – executive interview

Investment Companies | Update

BB Biotech — Lower rates and news flow to support recovery

Investment Companies | Flash note

BB Biotech — Positive trial news lifts two portfolio holdings

Healthcare business concept, Medical examination and growth graph data of business on tablet with doctor's health report clipboard on background.

Equity Analyst

Joanne Collins

Joanne Collins

Analyst, Investment Trusts

Key Management

  • Claude Mikkelsen

    Director of IR

  • Daniel Koller

    Head of investment management

  • Dr Silvia Siegfried-Schanz

    Director of IR

  • Erich Hunziker

    Chairman

Research

Flash note

Investment Companies

BB Biotech — Positive trial news lifts two portfolio holdings

Review

Investment Companies

BB Biotech — A recovering sector with a healthy prognosis

Healthcare business concept, Medical examination and growth graph data of business on tablet with doctor's health report clipboard on background.

Update

Investment Companies

BB Biotech — A cutting-edge sector and a high dividend

Healthcare business concept, Medical examination and growth graph data of business on tablet with doctor's health report clipboard on background.

Update

Investment Companies

BB Biotech — Picking growth at good value

edison tv

Investment Companies

BB Biotech – executive interview

Review

Investment Companies

BB Biotech — Great valuation potential

edison tv

Investment Companies

BB Biotech – executive interview

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free